MyMetabolon Login
© 2021 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Microbiome
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
    • Publications
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
    • Publications
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Company News & Press

Metabolon Announces Chief Financial Officer Transition
14 February 2022

Metabolon Announces Chief Financial Officer Transition

“We are thrilled to welcome Gerry to Metabolon during this strategic growth phase as we expand the use of metabolomics across the life sciences, including drug discovery and development. Gerry has a strong track record of success as a multi-faceted CFO, leading companies spanning the high-tech, biotech, medtech, and manufacturing sectors,” said Rohan Hastie, Ph.D., President and CEO of Metabolon.
Metabolon to Power Metabolomic Enriched Population Health Studies at FinnGen
24 January 2022

Metabolon to Power Metabolomic Enriched Population Health Studies at FinnGen

As a leading biobank research project based in Finland, FinnGen will incorporate deep metabolomic datasets to better understand how genetic drivers of disease may impact biological function and influence disease progression.
Leading medical centers leverage metabolomics to better understand the impact of lactation on birth and maternal outcomes
13 December 2021

Leading medical centers leverage metabolomics to better understand the impact of lactation on birth and maternal outcomes

Metabolon will collaborate with Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center (BIDMC) in a first-of-its-kind Lactation Lab, providing comprehensive metabolomic profiles to enhance understanding of the biology underlying lactation to identify solutions to improve maternal and infant health.
Load more

Find Us at These Events

Watch On-Demand Webinars
Event: Precision Medicine World Conference (PMWC)
28 June 2022

Event: Precision Medicine World Conference (PMWC)

January 26-28, 2022 Santa Clara Convention Center Silicon Valley, CA PMWC, the “Precision Medicine World Conference” is the largest &...
Webinar: Integrated Multiomic Analysis for Disease
27 April 2022

Webinar: Integrated Multiomic Analysis for Disease

April 27th 10:00 am EDT/16:00 CEST Multiomic analyses across a broad range of diseases are increasingly being utilized to better...
Metabolomics in drug discovery: The missing piece for multi-omics data
13 April 2022

Metabolomics in drug discovery: The missing piece for multi-omics data

April 13th 11:00 am EDT/17:00 CEST Scientists are increasingly using metabolomics together with other omics tools to better inform and...
Lunch and Learn: Applications of Metabolomics in Microbiome Research
2 February 2022

Lunch and Learn: Applications of Metabolomics in Microbiome Research

February 2, 2022 6:00 am EST/12:00pm CET Metabolites are critical signaling molecules that mediate host-microbiome communication and dynamics. Microbial bioactive...
Webinar: Customize, Accelerate, Improve: Applications of Metabolomics in Bioprocessing
17 November 2021

Webinar: Customize, Accelerate, Improve: Applications of Metabolomics in Bioprocessing

November 17th 6:00 am EST/12:00 pm CET Customize and improve your systems and processes: Identify crucial metabolic traits and optimal...
Event: Microbiome Connect: Gut Therapeutics
17 November 2021

Event: Microbiome Connect: Gut Therapeutics

Microbiome Connect: Gut Therapeutics will bring you essential solutions to the array of challenges operating in the microbiome field. The event will facilitate your discussions, uniting academics, biotechs and other industry stakeholders to share their exclusive research and innovation. Hear from big pharma to understand what they look for in a partner.
Webinar:  Demystifying the Microbiome: Connecting Metabolomics to Health and Drug Response
10 November 2021

Webinar: Demystifying the Microbiome: Connecting Metabolomics to Health and Drug Response

November 10th 11:00 am EST/17:00 CET Interest in the role of the human microbiome in health and disease is exploding....
Event: World Bioprocessing Summit
27 October 2021

Event: World Bioprocessing Summit

October 27th – 29th Metabolon is attending the World Bioprocessing Summit in Berlin this October. Field Application Scientist Svenja Heischmann,...
Webinar: Meet Smart: Metabolon and DNA Genotek unveil new microbiome research innovations that will change how we view the gut microbiota
27 October 2021

Webinar: Meet Smart: Metabolon and DNA Genotek unveil new microbiome research innovations that will change how we view the gut microbiota

October 27th 11:00 am EDT/17:00 CEST The disruption of the gut microbiome is linked to a growing number of disease...
Event: Microbiome R&D & Business Collaboration Forum: Europe
26 October 2021

Event: Microbiome R&D & Business Collaboration Forum: Europe

October 26th – 27th Metabolon is pleased to participate in the Microbiome R&D & Business Collaboration Forum: Europe. Field Application...
Load more

Enlighten your research,
accelerate your discovery.

Demo Our Data

Contact Us

Talk with an expert

Request a quote for our services or more information on sample types and handling procedures, need a letter of support, or simply have questions about how metabolomics can advance your research.

    Get a Project Quote
    Send a Message
    Corporate Headquarters

    617 Davis Drive, Suite 100
    Morrisville, NC 27560

    Mailing Address:
    P.O. Box 110407
    Research Triangle Park, NC  27709

    +1 (919) 572-1711
    +1 (919) 572-1721
    International Headquarters

    Metabolon GmbH

    Zeppelinstraße 3
    85399 Hallbergmoos
    Germany

    +49 89 99017752

    Metabolomics

    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Insights & Discoveries

    Solutions

    • Products & Services
    • By Research & Development Phase
    • By Therapeutic Area
    • By Sector

    Insights

    • Our Latest Insights
    • Blog
    • News & Events
    • Publications

    Resources

    • Resource Library
    • Client Stories
    • COVID-19

    Company

    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
    Metabolon - Logo - Enlightening Life

    Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

    © 2022 Metabolon, Inc. All rights reserved. Privacy & Terms

    in